Genoa Pharmaceuticals competitorsClear all

Genoa Pharmaceuticals's top competitors include Retrophin, Palatin Technologies, Omeros and Albireo Pharma.
Genoa Pharmaceuticals
Genoa Pharmaceuticals
Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.
Retrophin
Retrophin
Retrophin is a biopharmaceutical company which focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
Palatin Technologies
Palatin Technologies
Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases.
Omeros
Omeros
Omeros Corporation is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.
Albireo Pharma
Albireo Pharma
Albireo, a biotechnology company, develops therapeutic drugs for gastrointestinal diseases.
Founding Date
Founding Date
2011
Founding Date
2011
Founding Date
1986
Founding Date
1994
Founding Date
2003
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Seattle, US HQ
Locations
San Diego, US HQ
Dublin, IE
Cambridge, US
Locations
Cranbury Township, US HQ
Locations
Seattle, US HQ
Locations
Boston, US HQ
Göteborg, SE
Employees
Employees
2
Employees
2213% increase
Employees
185% decrease
Employees
2589% increase
Employees
5541% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1 b
Valuation ($)
123.3 m
Valuation ($)
756.1 m
Valuation ($)
738.7 m
Twitter followers
Twitter followers
N/A
Twitter followers
14
Twitter followers
530
Twitter followers
239
Twitter followers
328
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
18
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
20.5
Average likes per tweet (last 30 days)
3.3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
77.78%
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
302733
Alexa Website Rank
271668
Alexa Website Rank
337813
Alexa Website Rank
161771
Employee Rating
Employee Rating
N/A
Employee Rating
4.2
Employee Rating
4
Employee Rating
3.3
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$175.3m (FY, 2019)
Revenue (est.)
$60.3m (FY, 2019)
Revenue (est.)
$111.8m (FY, 2019)
Revenue (est.)
$9.6m (FY, 2019)
Cost of goods
Cost of goods
N/A
Cost of goods
$5.2m (FY, 2019)
Cost of goods
N/A
Cost of goods
$865k (FY, 2019)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$170.1m (FY, 2019)
Gross profit
N/A
Gross profit
$110.9m (FY, 2019)
Gross profit
N/A
Net income
Net income
N/A
Net income
($146.4m) (FY, 2019)
Net income
$35.8m (FY, 2019)
Net income
($84.5m) (FY, 2019)
Net income
($62.7m) (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 64.2m
Total funding raised
$ 116m
Total funding raised
$ 104.2m
Total funding raised
$ 354.8m
Total funding raised
$ 40m
For sources of this data, please see the company profile

View company profiles

Retrophin
HQ
San Diego, US
Employees
221↑ 3% increase

Retrophin is a biopharmaceutical company which focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.

View company
Palatin Technologies
HQ
Cranbury Township, US
Employees
18↓ 5% decrease

Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases.

View company
Omeros
HQ
Seattle, US
Employees
258↑ 9% increase

Omeros Corporation is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.

View company
Albireo Pharma
HQ
Boston, US
Employees
55↑ 41% increase

Albireo, a biotechnology company, develops therapeutic drugs for gastrointestinal diseases.

View company